Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Targeted Search
Clinical Trials Search Results
Query: "TILT[LastUpdatePostDate]SEARCH[Study]AREA[SponsorSearch]Mitsubishi Tanabe Pharma Corporation"
Count: 164
Selected: 0
| NCT ID | Title |
|---|
| NCT00501046 | A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease Including Assessment of Quality of Life (EPPIC-2) | ||
| NCT00500682 | A Study of AST-120 for Evaluating Prevention of Progression In Chronic Kidney Disease (EPPIC-1) | ||
| NCT05240612 | A Clinical Pharmacological Study of MT-3921 in Subjects With HTLV-1 Associated Myelopathy (HAM) | ||
| NCT05198557 | A Study of MT-0551 in Patients With Systemic Sclerosis | ||
| NCT03176771 | Efficacy and Safety of MT-5199 in Subjects With Tardive Dyskinesia | ||
| NCT05658562 | A Study of MT-2111 in Patients With Relapsed/Refractory DLBCL | ||
| NCT03245008 | Efficacy and Safety of MT-5547 in Patients With Osteoarthritis Accompanied by Moderate to Severe Pain | ||
| NCT03664544 | PK Study in Subjects With Severe Hepatic Impairment | ||
| NCT03289234 | Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Hepatic Impairment | ||
| NCT03289208 | Pharmacokinetics Study of MCI-186 in Subjects With Mild or Moderate Renal Impairment | ||
| NCT05568615 | Extension Study Following the Studies MT-1186-A03 or A04 to Evaluate the Safety of Oral Edaravone in Subjects With ALS | ||
| NCT05396235 | A Clinical Pharmacology Study of MT-3921 in Healthy Adult Males | ||
| NCT05123196 | Exploratory Study of MT-8554 in Subjects With Painful Diabetic Peripheral Neuropathy | ||
| NCT05342597 | Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Subjects (Food Effect Study) | ||
| NCT02924064 | Efficacy and Safety of Teneligliptin in Combination With Metformin in Chinese Patients With Type 2 Diabetes Mellitus | ||
| NCT02916706 | Efficacy and Safety of Teneligliptin in Chinese Patients With Type 2 Diabetes Mellitus | ||
| NCT03645863 | Effects of Iron Supplements on the Pharmacokinetics of MT-6548 | ||
| NCT03436693 | Efficacy and Safety of Canagliflozin (TA-7284) in Patients With Diabetic Nephropathy | ||
| NCT03439137 | Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Currently Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan | ||
| NCT03402386 | Efficacy and Safety Study to Evaluate MT-6548 in Peritoneal Dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan | ||
| NCT03329196 | Efficacy and Safety Study to Evaluate MT-6548 in Non-dialysis Subjects With Anemia Associated With Chronic Kidney Disease in Japan | ||
| NCT03461146 | Efficacy and Safety Study to Evaluate MT-6548 in Hemodialysis Subjects Not Receiving ESAs With Anemia Associated With Chronic Kidney Disease in Japan | ||
| NCT04776135 | Comparative Bioavailability Study of Oral Edaravone Administered Orally and Via a Nasogastric Tube | ||
| NCT01626885 | A Long-Term Study of MP-214 in Patients With Receiving Multiple Drugs Schizophrenia | ||
| NCT01625897 | A Long-Term Study of MP-214 in Patients With Chronic Phase or Elderly Schizophrenia | ||
| NCT01626872 | Long-Term Study of MP-214 in Patients With Schizophrenia | ||
| NCT01626859 | A Pharmacokinetic Study of MP-214 in Patients With Schizophrenia | ||
| NCT01625000 | Safety and Efficacy of MP-214 in Patients With Schizophrenia | ||
| NCT00862992 | Safety, Pharmacokinetics and Efficacy Study of MP-214 in Patients With Schizophrenia | ||
| NCT03891758 | Confirmatory Study of BK1310 in Healthy Infants | ||
| NCT04254913 | Clinical Pharmacology Study of Oral Edaravone in Amyotrophic Lateral Sclerosis Patients With Gastrostomy | ||
| NCT04493281 | Bioequivalence Study of Oral Suspension and Intravenous Formulation of Edaravone in Healthy Adult Subjects | ||
| NCT04481750 | Study of Oral Edaravone in Healthy Adult Males | ||
| NCT04481789 | Clinical Pharmacology Study of Oral Edaravone in Healthy Adult Males (Drug Interaction Study and Preliminary Regimen-Finding Study) | ||
| NCT04176224 | Clinical Pharmacology Study of Oral Edaravone in Patients With Amyotrophic Lateral Sclerosis | ||
| NCT01585155 | Clinical Study of TA-650 in Pediatric Patients With Ulcerative Colitis | ||
| NCT02923154 | Efficacy and Safety of MT-3995 in Patients With Non-Alcoholic Steatohepatitis(NASH) | ||
| NCT03507738 | Safety and Immunogenicity of MT-5625 in Healthy Adults, Toddlers and Infants | ||
| NCT01580670 | Clinical Study of TA-650 in Pediatric Patients With Crohn's Disease | ||
| NCT04029090 | A Study to Evaluate the Effect of MCI-186 at Therapeutic and Supra-Therapeutic Doses on the QT Interval(QT)/Corrected QT Interval(QTc) Interval in Healthy Subjects | ||
| NCT02622113 | Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With Insulin in Patients With Type 2 Diabetes Mellitus | ||
| NCT02227849 | Long-Term Safety Study of Canagliflozin (TA-7284) in Combination With GLP-1 Analogue in Patients With Type 2 Diabetes Mellitus | ||
| NCT03188692 | Safety and Efficacy of BK1310 Intramuscular Injection in Healthy Infants | ||
| NCT02992925 | Phase 3 Study of BK1310 in Healthy Infants | ||
| NCT03570957 | A Clinical Pharmacology Study of MT-2990 in Seasonal Allergic Rhinitis Patients | ||
| NCT01492686 | Phase 3 Study of MCI-186 for Treatment of Amyotrophic Lateral Sclerosis | ||
| NCT02354235 | Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Canagliflozin) | ||
| NCT02354222 | Confirmatory Study of MT-2412 in Japanese Patients With Type 2 Diabetes (Add-on Study of Teneligliptin) | ||
| NCT02220907 | Long-Term Safety Study of MT-2412 in Japanese Patients With Type 2 Diabetes | ||
| NCT01753570 | Efficacy and Safety of MP-424, Interferon Beta (IFN Beta), and Ribavirin(RBV) in Treatment-Naïve or Having Received Interferon Based Therapy With Chronic Hepatitis C (CHC) |
